Nektar Therapeutics (NASDAQ:NKTR) operates as a biopharmaceutical company that discovers and develops therapies to treat ...

Farther Finance Advisors LLC lessened its holdings in Toll Brothers, Inc. (NYSE:TOL – Free Report) by 61.8% in the 4th ...

MOSCOW — USA Today sports columnist Christine Brennan will deliver the keynote address at the University of Idaho’s ...

Oppenheimer lowered shares of Jefferies Financial Group (NYSE:JEF – Free Report) from an outperform rating to a market perform rating in a report released on Wednesday, MarketBeat.com reports. JEF has ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...

Jack Quaid has looked back on his time on the set of Christopher Nolan's Oppenheimer, revealing the acclaimed director paid ...

In a report released yesterday, Rick Schafer from Oppenheimer reiterated a Buy rating on Monolithic Power (MPWR – Research Report), with a ...

NeueHealth Inc (NEUE) is expected to report for 4Q. NeuroMetrix Inc (NURO) is expected to report for 4Q. Nikola Corp (NKLAQ) is expected to report for 4Q. Nu Ride Inc (NRDE) is expected to report for ...

As previously reported, Oppenheimer upgraded Mosaic (MOS) to Outperform from Perform with a $33 price target While the firm sees the potential ...

Fintel reports that on March 19, 2025, Oppenheimer downgraded their outlook for Goldman Sachs Group (NYSE:GS) from Outperform ...

More than a year after Warner Bros. shelved “Coyote vs. Acme” for tax incentives, the Looney Tunes-inspired film is close to ...

Christopher Nolan is working on an adaption of Homer's epic poem "Odyssey" though it is not yet known how he plans to adapt ...